发明名称 SUBSTITUTED BENZOLACTAM COMPOUNDS AS SUBSTANCE P ANTAGONISTS
摘要 This invention provides a compound of general formula (I) and its pharmaceutically acceptable salts, wherein: W is methylene, ethylene, propylene, vinylene, -CH2-O-, -O-CH2-, -CH2-S- or -S-CH2-; R<1>, R<2> and R<3> are independently hydrogen, C1-C3 alkyl, C1-C3 alkoxy or halo C1-C3 alkyl, provided that when W is methylene, both R<2> and R<3> are not hydrogen; X is halo, C1-C3 alkoxy, C1-C3 alkyl, halo C1-C3 alkoxy or C1-C3 alkenyl; Y is imino or oxy; Q is oxygen or sulfur; and T is (2S,3S)-2-diphenylmethylquinuclidin-3-yl, (2S,3S)-2-phenylpiperidin-3-yl or (2S,3S)-2-diphenylmethyl-1-azanorbornan-3-yl. These compounds are useful in the treatment of treating gastrointestinal disorders, central nervous system disorders, inflammatory diseases, emesis, urinary incontinence, pain, migraine, angiogensis or the like in a mammaliam subject, especially humans. Also, intermediates of the above compounds are disclosed.
申请公布号 WO9703066(A1) 申请公布日期 1997.01.30
申请号 WO1996IB00434 申请日期 1996.05.09
申请人 PFIZER PHARMACEUTICALS INC.;PFIZER INC.;WAKABAYASHI, HIROAKI;IKUNAKA, MASAYA 发明人 WAKABAYASHI, HIROAKI;IKUNAKA, MASAYA
分类号 C07D401/12;A61K31/40;A61K31/435;A61K31/439;A61K31/4427;A61K31/445;A61K31/454;A61K31/47;A61K31/4709;A61K31/505;A61K31/535;A61K31/536;A61K31/538;A61K31/54;A61K31/5415;A61K31/55;A61P1/00;A61P13/00;A61P13/02;A61P15/00;A61P25/00;A61P25/04;A61P29/00;A61P43/00;C07D211/56;C07D403/12;C07D413/12;C07D417/12;C07D453/02;C07D471/08;(IPC1-7):C07D401/12;C07D265/18;C07D265/28;C07D279/08;C07D279/10 主分类号 C07D401/12
代理机构 代理人
主权项
地址